Market Place
Sourcing Support
Amgen sticks by Lumakras dose as ESMO data boost confidence
22 Oct 2023 //
FIERCE PHARMA
Lumakras With Vectibix Shows Confirmed 30% Objective Response Rate In Patients
12 Sep 2022 //
PRNEWSWIRE
Amgen drug extends survival in some inoperable colon cancers
06 Jun 2022 //
REUTERS
LUMAKRAS + Vectibix Shows Better Results In KRAS G12C-Mutated Colorectal Cancer
16 Sep 2021 //
PRNEWSWIRE
Amgen`s Biological Panitumumab Receives Approval In the US
25 Aug 2021 //
FDA
Collaboration of GNS Healthcare, Amgen & Clinical Trials in Oncology
06 Sep 2018 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.